Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
25,000
-300 (-1.19%)
Feb 27, 2026, 3:30 PM KST
61.08%
Market Cap 174.22B
Revenue (ttm) 66.51B
Net Income (ttm) 2.32B
Shares Out 6.97M
EPS (ttm) 340.76
PE Ratio 73.37
Forward PE n/a
Dividend 1,200.00 (4.80%)
Ex-Dividend Date Dec 29, 2025
Volume 15,998
Average Volume 30,925
Open 25,650
Previous Close 25,300
Day's Range 24,650 - 25,700
52-Week Range 14,500 - 31,450
Beta -0.34
RSI 54.98
Earnings Date Feb 26, 2026

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.